Learning Objectives:
1. Discuss the ADA recommendations for glucagon-like peptide-1 (GLP-1) receptor agonist and sodium-glucose cotransporter-2 (SGLT2) inhibitor use
2. Identify resources available for medication access assistance
3. Understand how to implement new ADA diabetes management guidelines into daily practice
Session date:
07/27/2021 - 7:00am to 8:00am CDT
Location:
UChicago Care Network - Primary Care
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Sarah Pérez, PharmD, BCACP, AAHIVP